CAPSAICIN REGULAR CREAM 0.05 %
CAPSAICIN : 0.05 % · DIN 02150115 · WEX PHARMACEUTICALS INC
Health Canada status: CANCELLED POST MARKET
What is CAPSAICIN REGULAR CREAM?
CAPSAICIN REGULAR CREAM 0.05 % contains CAPSAICIN : 0.05 %. It is listed in the Health Canada Drug Product Database under DIN 02150115, held by WEX PHARMACEUTICALS INC, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 31-Aug-2009. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is CAPSAICIN REGULAR CREAM called?
The same molecule, CAPSAICIN AND SIMILAR AGENTS, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Qutenza | Latin | Bahrain, Iceland, Norway |
| Capsina | Latin | Iceland |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02150115 |
|---|---|
| Brand name | CAPSAICIN REGULAR CREAM |
| Generic / active ingredient | CAPSAICIN : 0.05 % |
| Manufacturer | WEX PHARMACEUTICALS INC |
| Strength | 0.05 % |
| Dosage form | CREAM |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | M02AB CAPSAICIN AND SIMILAR AGENTS |
| AHFS class | 84:24.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 31-Aug-2009 |
| Original market date | 1995-03-06 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02150115 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2150115 |
| Brand name | CAPSAICIN REGULAR CREAM |
| Active ingredient / INN | CAPSAICIN : 0.05 % |
| ATC code | M02AB |
| ATC anatomical main group | M — Musculo-skeletal system |
| ATC therapeutic subgroup | M02 |
| AHFS class | 84:24.04 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | WEX PHARMACEUTICALS INC |
Which pack is which?
| Strength on the label | 0.05 % |
|---|---|
| Dosage form | CREAM |
| Route | TOPICAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code M02AB CAPSAICIN AND SIMILAR AGENTS. 0 of 19 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ARTHRICARE FOR WOMEN MULTI-ACTION | 1.25 % | CREAM | DEL PHARMACEUTICS (CANADA) INC. | CANCELLED POST MARKET | DIN 01935046 |
| BENEJOINT | 0.025 % | CREAM | LANE LABS-USA, INC. | CANCELLED POST MARKET | DIN 02239488 |
| BIOBALSAM | 0.75 % | CREAM | BIOPHARMATECH INC. | CANCELLED POST MARKET | DIN 02230695 |
| BORN AGAIN SUPER PAIN RELIEVING LOTION | 0.025 % | LOTION | ALVIN LAST, INC. | CANCELLED POST MARKET | DIN 02236788 |
| CAPSAICIN CREAM 0.025% | .025 % | CREAM | FERNDALE LABORATORIES INC. | CANCELLED POST MARKET | DIN 02185717 |
| CAPSAICIN FORTE CREAM | 0.075 % | CREAM | WEX PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 02150123 |
| CAPSAICIN MILD CREAM | 0.025 % | CREAM | WEX PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 02150107 |
| CAPSODAN CREAM | 4 % | CREAM | ODAN LABORATORIES LTD | CANCELLED PRE MARKET | DIN 02231073 |
| CAPZASIN-P CREME - 0.025% | .025 % | CREAM | STELLA PHARMACEUTICAL CANADA INC. | CANCELLED POST MARKET | DIN 02174308 |
| FINALGON ONT | 2.5 % | OINTMENT | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | CANCELLED POST MARKET | DIN 00067423 |
Who else supplies CAPSAICIN AND SIMILAR AGENTS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CAPSAICIN AND SIMILAR AGENTS appears in 11 registered pack listings across 4 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does CAPSAICIN AND SIMILAR AGENTS cost around the world?
CAPSAICIN AND SIMILAR AGENTS is listed on 5 national price registers Nexara tracks, across 18 pack listings published on 5 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 4 | 7 | 03 Sep 2026 |
| Greece | producer price (ex-factory) | 6 | 6 | 03 Sep 2026 |
| Bahrain | retail (max) | 1 | 2 | 01 Sep 2026 |
| Iceland | max wholesale | 2 | 2 | 02 Sep 2026 |
| Norway | max AUP (pharmacy retail) | 1 | 1 | 07 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.